As of November 2016, more than 9,000 lawsuits have been filed against the makers and distributers of Xarelto, a prescription blood thinner. Xarelto is manufactured by Bayer AG and distributed in the U.S. by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Xarelto has several uses, including: reducing the risk of stroke in patients with nonvalvular atrial fibrillation; treating deep vein thrombosis and pulmonary embolism, and reducing the recurrence of these conditions; and preventing blood clots in patients following knee or hip surgery. Xarelto can cause severe, uncontrolled internal bleeding which causes patients a number of problems and can lead to death.
In 2015, the U.S. Food and Drug Administration received a total of 10,674 reports involving patients on Xarelto, including 1,121 patient deaths and 4,508 injuries requiring hospitalization. This shows that Xarelto was responsible for the largest number of reported cases of domestic, serious injury among regularly monitored drugs in that year.
If you or someone you know has suffered internal bleeding after taking Xarelto, contact our office to find out what your legal options are.